OPKO Health's (OPK) fourth-quarter results benefit from strength in diagnostics.
Opko Health Inc (NASDAQ: OPK) reported Q4 results that came in above expectations with EPS of $0.05 beating the estimate of $0.04 and sales of $494.6 million higher than the consensus of $443.1 mi
Hint: Investors are more focused on concerns about the future than successes of the recent past.
OPKO Health, Inc. (OPK) CEO Dr. Phillip Frost on Q4 2020 Results - Earnings Call Transcript
OPKO Health (OPK) delivered earnings and revenue surprises of 25.00% and 13.41%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

OPKO Health: Q4 Earnings Insights

04:38pm, Thursday, 18'th Feb 2021
Shares of OPKO Health (NASDAQ:OPK) rose in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 266.67% over the past year to $0.05, which beat the est
OPKO Health's (OPK) fourth-quarter results are likely to reflect solid performance from Services and Products segment and RAYALDEE.
MIAMI, Feb. 03, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended December 31, 2020, as well as discuss financial guid

10 Short Squeeze Candidates Under $10

08:36am, Saturday, 30'th Jan 2021
The movement of retail traders against hedge funds has caused several stocks to spike. Many of the top movers have been stocks that have a high percentage of their floated shares short, causing what's

7 Best Penny Stocks to Buy Early Into 2021

05:16am, Tuesday, 19'th Jan 2021
Penny stocks are cheap for a reason, as there are obvious flaws. However, with those flows comes opportunity.
OPKO Health's (OPK) BioReference introduces an in-home, fully-integrated digital platform providing access to diagnostic services.
OPKO Health, Inc. (OPK) CEO Phil Frost Presents at 39th Annual JPMorgan Virtual Healthcare Conference (Transcript)
ELMWOOD PARK, N.J., Jan. 13, 2021 /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today introduced Scarlet Health™, an in-home, fully integrated digital platfor
Calls on Analysts and Stockholders Attending J.P. Morgan's Healthcare Conference to Determine Whether Management Disputes our Analysis and Stands by Original 4Q'20 Guidance Calls on Analysts and Stock
OPKO Health (OPK) closed the most recent trading day at $4.48, moving +1.82% from the previous trading session.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE